Diabetic Retinopathy
Intravitreal triamcinolone has a fleeting effect on diabetic macular edema
Published in Diabetes Week, August 1st, 2005
"Diabetic macular edema is a frequent cause of visual loss in patients with diabetic retinopathy. The purpose of this study was to assess the efficacy of intravitreal triamcinolone acetonide in reducing diabetic macular edema and improving visual acuity," researchers in Austria report.
"In this prospective study 12 eyes of 12 patients with diabetic macular oedema unresponsive to prior laser treatment received an intravitreal injection of 4 mg triamcinolone acetonide. Examinations were performed 1 day preoperatively and at 1 week and 1, 3, 6, and 9 months after surgery and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Diabetes Week
Source: Diabetes Week (2005-08-01)
More Articles from Diabetes Week
- Diabetes Therapy
Insulin pumps not better than insulin injections in young diabetic children - Diabetic Nephropathy
Intercellular adhesion molecule deficiency prevents diabetic nephropathy - Heart Disease Risk Factors
Fatty acid metabolism is enhanced in type 2 diabetic hearts - Insulin Resistance
Diet-induced brain insulin resistance characterized - Insulin Resistance
Elevated gamma-glutamyltransferase levels predict reduced insulin sensitivity - Adverse Drug Reaction
Report describes commonly used meds that worsen insulin resistance - More from this issue of Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
